Optimizing orthotic management in children with cerebral palsy to improve mobility and participatio

Completed

• Conditions: brain damage; spasticity; 10010335

• Registration Number: NL-OMON37433
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

- children diagnosed with spastic Cerebral Palsy
- children aged between 6 and 14 years
- a gait pattern that is characterized by excessive knee flexion
- Gross motor function classification score (GMFCS) I - III, provided that the patient is able perform a 3D-gait analysis without walking aids
- ability to walk independently for at least five minutes at a comfortable walking speed (CWS).

Exclusion Criteria

- orthopaedic surgery or other surgical interventions that might influence mobility in the past 6 months
- Botulinum Toxin A injections in the past three months
- intrathecal Baclofen (ICB) therapy in the last six months or selective dorsal rhizotomy (SDR) in the past year
- impairments that contra indicate fitness tests
- severe joint contractures
- severe behavioural problems

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary study parameters of this study are:<br /><br>- energy cost of walking (J/kg/m)<br /><br>- the child*s daily activity (steps/day)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary study parameters are:<br /><br>- gait biomechanics<br /><br>- diversity, intensity and enjoyment of participation<br /><br>- walking speed (m/s)</p><br>